Evidence map›Paper›PMID 18350254›Full record

ArticleClinical & experimental metastasis2008

GRP-induced up-regulation of Hsp72 promotes CD16+/94+ natural killer cell binding to colon cancer cells causing tumor cell cytolysis.

Lauren Taglia, Damien Matusiak, Richard V Benya

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lauren TagliaDepartment of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Damien Matusiak
Richard V Benya
Jesse Brown VA Medical Center · USUniversity of Illinois Chicago · US

Funding

Gastrin-Releasing Peptide Receptor DesensitizationR01CA094346 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BENYA, RICHARD V · 2003 to 2007
$1.4M
NCI NIH HHS CA 094346
6 · The paper itself

Abstract

Gastrin-releasing peptide (GRP) and its receptor (GRPR) are not normally expressed by epithelial cells lining the adult human colon. However post malignant transformation both GRP and its receptor are aberrantly expressed in the colon where we have previously shown they act to retard metastasis by enhancing tumor cell attachment to the extracellular matrix. In the present study, we show that GRP signaling via its cognate receptor when both are aberrantly expressed in human colon cancer cells causes heat shock protein 72 (Hsp72) to be expressed. We show that GRP/GRPR induces expression of Hsp72 by signaling via focal adhesion kinase. When expressed, Hsp72 promotes the binding of CD16+ and CD94+ natural killer cells, resulting in tumor cell cytolysis. These findings demonstrate the presence of a novel mechanism whereby aberrantly expressed GRP/GRPR in human colorectal cancer attenuates tumor progression and may promote a favorable outcome.

Indexed as

Cytotoxicity, ImmunologicCell Line, TumorColonic NeoplasmsFocal Adhesion Protein-Tyrosine KinasesGastrin-Releasing PeptideHSP72 Heat-Shock ProteinsHumansKiller Cells, NaturalNK Cell Lectin-Like Receptor Subfamily DReceptors, BombesinReceptors, IgGSignal TransductionUp-RegulationFocal Adhesion Protein-Tyrosine KinasesGastrin-Releasing PeptideHSP72 Heat-Shock ProteinsKLRD1 protein, humanNK Cell Lectin-Like Receptor Subfamily DReceptors, BombesinReceptors, IgG

Identifiers

PMID18350254
OpenAlexW2016174756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.